drugset / Trial / NCT02485704
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the complete cure of scabies after a single treatment.
Timeline
- Start
- 2017-05-10
- Primary completion
- 2018-08-03
- Completion
- 2018-08-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Spinosad | Small molecule | 0.9 % | Topical |
| Subject | Spinosad | Small molecule | 120 ml | Topical |